The potential of UK clinical databases in enhancing paediatric medication research

The potential of UK clinical databases in enhancing paediatric medication research

Wong IC; Murray ML

British Journal of Clinical Pharmacology

2005

Non-U.S. Gov't; PedPal Lit; Newborn Medical Records Systems; Adolescent Adverse Drug Reaction Reporting Systems Biomedical Research/methods Child Child; Computerized Pediatrics/methods Pharmaceutical Preparations/administration & dosage Pharmacoepidemiology/methods Prescriptions; Drug/statistics & numerical data Research Support; Factual Family Practice/statistics & numerical data Great Britain Humans Infant Infant; PreschoolDatabases

The research potential of many UK clinical databases is not being realized. A recent report published by the Royal College of Paediatrics & Child Health stated that there is a need to build research capacity and support in the area of paediatric pharmacology, with specific emphasis on the use of clinical databases. This article presents the databases available in the UK for medication research and gives some examples of paediatric studies conducted. The databases discussed include the Prescription Pricing Authority database, the General Practice Research Database, IMS Health databases (Medical Data Index, MIDAS Prescribing Insights, Disease-Analyser-Mediplus) and the Yellow Card Scheme. Other databases such as the Medicines Monitoring Unit (MEMO) and the Scottish Primary Care Computer System also have research potential in paediatric pharmacoepidemiology, but their population sizes are relatively small.

2005

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Journal Article

Backlog